Mason Street Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ICPT
CG
O
FAM
Mason Street Advisors's ICPT Position: Q1 2015 in Review
Mason Street Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015, closing a stake of 1,350 shares — an estimated $211K sold.
Mason Street Advisors first reported a position in ICPT in Q2 2014 and held it in 3 quarters. The position peaked at $334K in Q3 2014. 200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.
- Mason Street Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
- Mason Street Advisors sold 1,350 Intercept Pharmaceuticals, Inc. shares in Q1 2015, an estimated $211K.
- Mason Street Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
- Mason Street Advisors's Intercept Pharmaceuticals, Inc. position peaked at $334K in Q3 2014.
- 200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.
Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.